Detalhe da pesquisa
1.
Opportunities to improve the adoption of health-related quality of life evidence as part of the French Health Technology Assessment process.
Health Res Policy Syst
; 21(1): 137, 2023 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38115078
2.
IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma.
Blood
; 136(14): 1657-1669, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32573700
3.
Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target.
Haematologica
; 106(6): 1693-1704, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32327503
4.
From bench to bedside: the past, present and future of therapy for systemic paediatric ALCL, ALK.
Br J Haematol
; 185(6): 1043-1054, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30681723
5.
The evolving value assessment of cancer therapies: Results from a modified Delphi study.
Health Policy Open
; 6: 100116, 2024 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38464704
6.
Treatment Options for Paediatric Anaplastic Large Cell Lymphoma (ALCL): Current Standard and beyond.
Cancers (Basel)
; 10(4)2018 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29601554
7.
STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma.
Leukemia
; 35(5): 1500-1505, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33247178